SCHEMBL22520118

SCHEMBL22520118

C=CC(=O)Nc1cc(Nc2ncc(F)c(Nc3ccccc3P(C)(C)=O)n2)c(OC)cc1N1CCC(N2CCN(C)CC2)CC1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALK Q9UM73 13/20 0.71
▸ INSR P06213 9/20 0.71
▸ IGF1R P08069 9/20 0.71
▸ EGFR P00533 9/20 0.62
▸ EML4 Q9HC35 2/20 0.61
▸ CHEK1 O14757 1/20 0.61
▸ AURKA O14965 1/20 0.61
▸ NUAK1 O60285 1/20 0.61
▸ JAK2 O60674 1/20 0.61
▸ STK10 O94804 1/20 0.61
▸ PRKD3 O94806 1/20 0.61
▸ SLC34A2 O95436 1/20 0.61
▸ CHEK2 O96017 1/20 0.61
▸ ABL1 P00519 1/20 0.61
▸ CD74 P04233 1/20 0.61
▸ ERBB2 P04626 1/20 0.61
▸ LCK P06239 1/20 0.61
▸ FYN P06241 1/20 0.61
▸ FES P07332 1/20 0.61
▸ CSF1R P07333 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22497639 0.93 ALK (0.71) ALKINSRIGF1REGFREML4
SCHEMBL16780916 0.92 ALK (0.78) ALKINSRIGF1REGFREML4
SCHEMBL31196996 0.92 ALK (0.78) ALKINSRIGF1REGFREML4
SCHEMBL16780721 0.90 ALK (0.74) ALKINSRIGF1REGFREML4
SCHEMBL15600820 0.90 ALK (0.74) ALKINSRIGF1REGFREML4
SCHEMBL29253608 0.90 EGFR (0.57) ALKINSRIGF1REGFR
SCHEMBL22520099 0.89 EGFR (0.67) ALKINSRIGF1REGFREML4
SCHEMBL16780999 0.89 ALK (0.72) ALKINSRIGF1REGFREML4
SCHEMBL22497624 0.88 EGFR (0.71) ALKINSRIGF1REGFR
SCHEMBL22520076 0.87 ALK (0.78) ALKINSRIGF1REGFREML4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113677680-A EGFR inhibitor and composition and application thereof 贝达药业股份有限公司 2021-11-19 — — CN disclosed
WO-2020200191-A1 EGFR INHIBITORS, COMPOSITIONS AND METHODS THERE OF BETTA PHARMACEUTICALS CO., LTD (CN) 2020-10-08 — — WO disclosed
Send feedback